TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Kala Pharmaceuticals
US Patent
Kala Pharmaceuticals
US Patent
Affinity DataKd: 1.10E+3nMAssay Description:A competition binding assay (DiscoveRx KINOMEscan) was used to measure the ability of the compound to compete for binding of an immobilized adenosine...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Kala Pharmaceuticals
US Patent
Kala Pharmaceuticals
US Patent
Affinity DataKd: 1.60E+3nMAssay Description:A competition binding assay (DiscoveRx KINOMEscan) was used to measure the ability of the compound to compete for binding of an immobilized adenosine...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Kala Pharmaceuticals
US Patent
Kala Pharmaceuticals
US Patent
Affinity DataKd: 1.30E+3nMAssay Description:A competition binding assay (DiscoveRx KINOMEscan) was used to measure the ability of the compound to compete for binding of an immobilized adenosine...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Kala Pharmaceuticals
US Patent
Kala Pharmaceuticals
US Patent
Affinity DataKd: 1.10E+3nMAssay Description:A competition binding assay (DiscoveRx KINOMEscan) was used to measure the ability of the compound to compete for binding of an immobilized adenosine...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Kala Pharmaceuticals
US Patent
Kala Pharmaceuticals
US Patent
Affinity DataKd: 410nMAssay Description:A competition binding assay (DiscoveRx KINOMEscan) was used to measure the ability of the compound to compete for binding of an immobilized adenosine...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Kala Pharmaceuticals
US Patent
Kala Pharmaceuticals
US Patent
Affinity DataKd: 1.00E+3nMAssay Description:A competition binding assay (DiscoveRx KINOMEscan) was used to measure the ability of the compound to compete for binding of an immobilized adenosine...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Kala Pharmaceuticals
US Patent
Kala Pharmaceuticals
US Patent
Affinity DataKd: 1.90E+3nMAssay Description:A competition binding assay (DiscoveRx KINOMEscan) was used to measure the ability of the compound to compete for binding of an immobilized adenosine...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Kala Pharmaceuticals
US Patent
Kala Pharmaceuticals
US Patent
Affinity DataKd: 1.10E+5nMAssay Description:A competition binding assay (DiscoveRx KINOMEscan) was used to measure the ability of the compound to compete for binding of an immobilized adenosine...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Kala Pharmaceuticals
US Patent
Kala Pharmaceuticals
US Patent
Affinity DataKd: 440nMAssay Description:A competition binding assay (DiscoveRx KINOMEscan) was used to measure the ability of the compound to compete for binding of an immobilized adenosine...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Kala Pharmaceuticals
US Patent
Kala Pharmaceuticals
US Patent
Affinity DataKd: 6.10E+3nMAssay Description:A competition binding assay (DiscoveRx KINOMEscan) was used to measure the ability of the compound to compete for binding of an immobilized adenosine...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Kala Pharmaceuticals
US Patent
Kala Pharmaceuticals
US Patent
Affinity DataKd: 2.50E+3nMAssay Description:A competition binding assay (DiscoveRx KINOMEscan) was used to measure the ability of the compound to compete for binding of an immobilized adenosine...More data for this Ligand-Target Pair